[EN] POLYCYCLIC AGENTS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS<br/>[FR] AGENTS POLYCYCLIQUES POUR LE TRAITEMENT D'INFECTIONS PAR LE VIRUS SYNCYTIAL RESPIRATOIRE
申请人:BIOTA SCIENT MANAGEMENT
公开号:WO2005061513A1
公开(公告)日:2005-07-07
Compounds of formula (I), and their use as in the treatment of infections involving viruses of the Pneumovirinae sub-family (RSV) are disclosed. In the formula ring (A) may be phenyl, pyridyl etc., (B-C) may be CH2-CH2 etc., (R1) may be phenyl and substituted forms thereof, (R2) may be assorted substituents.
A new class of chemical compounds whose members exert an appetite suppressant and mood elevating effect in man has been invented. This class is defined as being composed of those compounds having the 1-substituted-2,5-benzodiazocine structure, fully saturated in the nonbenzenoid portion, and whose nitrogens are tervalent. Members of this class are prepared by condensing an orthobenzoylbenzoic acid or ester thereof with an ethylenediamine and reducing with a metallic alkaline hydride the product thus obtained.
Polycyclic agents for the treatment of respiratory syncytial virus infections
申请人:Bond Silas
公开号:US20070287700A1
公开(公告)日:2007-12-13
Compounds of formula (I), and their use as in the treatment of infections involving viruses of the Pneumovirinae sub-family (RSV) are disclosed. In the formula ring (A) may be phenyl, pyridyl etc., (B-C) may be CH
2
—CH
2
etc., (R
1
) may be phenyl and substituted forms thereof, (R
2
) may be assorted substituents.
Polycyclic Agents for the Treatment of Respiratory Syncytial Virus Infections
申请人:Biota Scientific Management Pty Ltd.
公开号:US20140051689A1
公开(公告)日:2014-02-20
Compounds of formula (I), and their use as in the treatment of infections involving viruses of the Pneumovirinae sub-family (RSV) are disclosed. In the formula ring (A) may be phenyl, pyridyl etc., (B-C) may be CH
2
—CH
2
etc., (R
1
) may be phenyl and substituted forms thereof, (R
2
) may be assorted substituents.
Discovery of the First M<sub>5</sub>-Selective and CNS Penetrant Negative Allosteric Modulator (NAM) of a Muscarinic Acetylcholine Receptor: (<i>S</i>)-9b-(4-Chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1<i>H</i>-imidazo[2,1-<i>a</i>]isoindol-5(9b<i>H</i>)-one (ML375)
作者:Patrick R. Gentry、Masaya Kokubo、Thomas M. Bridges、Nathan R. Kett、Joel M. Harp、Hyekyung P. Cho、Emery Smith、Peter Chase、Peter S. Hodder、Colleen M. Niswender、J. Scott Daniels、P. Jeffrey Conn、Michael R. Wood、Craig W. Lindsley
DOI:10.1021/jm4013246
日期:2013.11.27
A functional high throughput screen and subsequent multidimensional, iterative parallel synthesis effort identified the first muscarinic acetylcholine receptor (mAChR) negative allosteric modulator (NAM) selective for the M-5 subtype. ML375 is a highly selective M-5 NAM with submicromolar potency (human M-5 IC50 = 300 nM, rat M-5 IC50 = 790 nM, M1-M4 IC50 > 30 mu M), excellent multispecies PK, high CNS penetration, and enantiospecific inhibition.